Oxytocic Pharmaceuticals Market
Description
Oxytocic Pharmaceuticals Market, By Indication (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Hemorrhage, Labor Induction, and Labor Arrest), By Route of Administration (Intramuscular, and Intravenous Injection/Infusion), By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin (Animal Pituitary Extract)), By End User (Hospitals, and Maternity Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.
Market Dynamics
The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Université to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.
Key features of the study:
This report provides an in-depth analysis of the global oxytocic pharmaceuticals market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market
Detailed Segmentation:
Global Oxytocic Pharmaceuticals Market, By Indication:
Abortion Induced Incomplete
Inevitable Abortion
Postpartum Hemorrhage
Labor Induction
Labor Arrest
Global Oxytocic Pharmaceuticals Market, By Route of Administration:
Intramuscular
Intravenous Injection/Infusion
Global Oxytocic Pharmaceuticals Market, By Source of Origin:
Synthetic Oxytocin
Natural Oxytocin (Animal Pituitary Extract)
Global Oxytocic Pharmaceuticals Market, By End User:
Hospitals
Maternity Clinics
Global Oxytocic Pharmaceuticals Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Fresenius Kabi AG *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Biofutura SpA
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Baxter Healthcare Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Ferring B.V.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abbott.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abbott
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
AdvaCare Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
EVER Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
160 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- 4. Global Oxytocic Pharmaceuticals Market – COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- 6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018–2030
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
- 7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Synthetic Oxytocin
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- 8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 – 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Maternity Clinics
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- 9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2018–2030
- North America
- Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 10. Competitive Landscape
- Company Profiles
- Fresenius Kabi AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biofutura SpA
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter Healthcare Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ferring B.V.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AdvaCare Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- EVER Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- 11. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 34 market data tables and 26 figures on “Oxytocic Pharmaceuticals Market” – Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
